Minor changes to methods after trial commencement
pneumonia
PNEUMONIA
For study inclusion, patients had to be negative for SARS-CoV-2 with a reverse-transcriptase polymerase chain reaction respiratory tract sample and radiologically (computed tomography) to exclude Covid-19 pneumonia. The study duration was initially planned for 15 months but was extended by 12 months. No changes were made to the study protocol.